You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 53 No. 2, August 1946 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (5)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

INTRAPERITONEAL ADMINISTRATION OF SUCCINYLSULFATHIAZOLE AND PHTHALYLSULFATHIAZOLE

Their Use in the Prophylaxis and Treatment of Peritonitis

JOHN P. YOUNG, Jr., M.D.; WARREN H. COLE, M.D.

Arch Surg. 1946;53(2):182-189.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

SHORTLY after the introduction of the sulfonamide drugs as antibiotics, they were used intraperitoneally as a prophylaxis against peritonitis. Innumerable reports indicated that they were effective, but most surgeons abandoned their intraperitoneal use when penicillin was made available, because it appeared to be more effective than the sulfonamide compounds. Of these two drugs penicillin appears definitely to be more helpful against colon bacilli, but neither can be classified as being extremely effective against these organisms. Although streptococci and other pyogenic bacteria are occasionally isolated as causative organisms in peritonitis Escherichia coli is much commoner and even when a mixed infection occurs it is usually the predominant organism. Therefore, in the treatment or prophylaxis of peritonitis there would appear to be a need for an antibiotic agent which would be more effective against Esch. coli.

The introduction of the oral use of succinylsulfathiazole in 1941 by Poth and Knotts1 and, . . . [Full Text PDF of this Article]


Author Affiliations

CHICAGO

From the Department of Surgery, University of Illinois College of Medicine and the Illinois Research and Educational Hospitals.


Footnotes

Mr. Everett Hoppe gave able assistance.

Aided by a grant from Sharp & Dohme, Inc.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1946 American Medical Association. All Rights Reserved.